Bone Biologics Corp (BBLG):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Bone Biologics Corp (BBLG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3049
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Bone Biologics Corp (Bone Biologics) is a biotechnology company that develops orthobiologic products. The company develops NELL-1, a recombinant human protein growth factor, which is essential for normal bone development. It offers bone graft substitutes for spine fusion. Bone Biologics also offers Nell-1/TCP fusion device, which is a single dose vial of Nell-1 recombinant protein freeze dried onto tricalcium phosphate and demineralized bone putty. The company’s technology has application in spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicines. It collaborates with manufacturing organizations to develop its products. The company markets its products domestic and internationally. Bone Biologics is headquartered in Burlington, Massachusetts, the US.

Bone Biologics Corp (BBLG) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Bone Biologics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Bone Biologics Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Bone Biologics Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Bone Biologics Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Bone Biologics Corp, Medical Devices Deals, 2012 to YTD 2018 9
Bone Biologics Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Bone Biologics Corp, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Bone Biologics Raises USD5 Million in Venture Financing 11
Merger 12
AFH Acquisition Merges with Bone Biologics in Reverse Merger Transaction 12
Equity Offering 13
Bone Biologics Raises USD3.9 Million in Private Placement of Shares 13
Bone Biologics Raises USD0.5 million in Second Tranche of Financing 14
Debt Offering 15
Bone Biologics Raises USD2 Million in Private Placement of 8.5% Notes Due 2019 15
Bone Biologics Corp – Key Competitors 16
Bone Biologics Corp – Key Employees 17
Bone Biologics Corp – Locations And Subsidiaries 18
Head Office 18
Recent Developments 19
Corporate Communications 19
Aug 03, 2017: Bone Biologics Announces Appointment of Bret Hankey to Company’s Board of Director 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Bone Biologics Corp, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Bone Biologics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Bone Biologics Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Bone Biologics Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Bone Biologics Corp, Deals By Therapy Area, 2012 to YTD 2018 8
Bone Biologics Corp, Medical Devices Deals, 2012 to YTD 2018 9
Bone Biologics Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Bone Biologics Raises USD5 Million in Venture Financing 11
AFH Acquisition Merges with Bone Biologics in Reverse Merger Transaction 12
Bone Biologics Raises USD3.9 Million in Private Placement of Shares 13
Bone Biologics Raises USD0.5 million in Second Tranche of Financing 14
Bone Biologics Raises USD2 Million in Private Placement of 8.5% Notes Due 2019 15
Bone Biologics Corp, Key Competitors 16
Bone Biologics Corp, Key Employees 17

List of Figures
Bone Biologics Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Bone Biologics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Bone Biologics Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Bone Biologics Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Bone Biologics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Bone Biologics Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Bone Biologics Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Bone Biologics Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Bone Biologics Corp, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Bone Biologics Corp (BBLG):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Luminex Corp (LMNX)-製薬・医療分野:企業M&A・提携分析
    Summary Luminex Corp (Luminex) is a medical devices company which develops, manufactures and markets proprietary biological testing technologies. The company offers wide range of products including instruments, assays, reagents and accessories, software and replacement parts. Its proprietary technol …
  • Nohla Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Nohla Therapeutics Inc (Nohla Therapeutics) focuses on the development of universal, off-the-shelf cell therapies for the treatment of hematologic malignancies and other critical diseases. The company develops clinical, preclinical and discovery programs based on its proprietary notch ligand …
  • Sanara MedTech Inc (WNDM):企業の財務・戦略的SWOT分析
    Summary Sanara MedTech Inc (Sanara MedTech), formerly WNDM Medical Inc is a distributor of biotechnology products to hospitals, physicians, and clinics. The company offers its patented product CellerateRX in powder and gel forms, and hemaquell resorbable bone wax that controls bone bleeding. Its pro …
  • TIVIT Terceirizacao de Tecnologia e Servicos SA:企業の戦略的SWOT分析
    TIVIT Terceirizacao de Tecnologia e Servicos SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competito …
  • Silex Systems Ltd (SLX):企業の財務・戦略的SWOT分析
    Summary Silex Systems Ltd (Silex) is a research and development company that offers technology solutions. The company develops, and commercializes technologies in solar energy, nuclear energy, and advanced materials and instrumentation. It develops utility-scale concentrating photovoltaic technology …
  • Semcon AB (SEMC):企業の財務・戦略的SWOT分析
    Summary Semcon AB (Semcon) is a technology company that offers product design and information services. The company’s services include production development, project management, designing, product development, and product information. Its designing services comprise visualization, industrial design …
  • Globo Comunicacao e Participacoes S.A.:企業の戦略的SWOT分析
    Globo Comunicacao e Participacoes S.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • UniCredit S.p.A:戦略・SWOT・企業財務分析
    UniCredit S.p.A - Strategy, SWOT and Corporate Finance Report Summary UniCredit S.p.A - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • BioGaia AB (BIOG B):企業の財務・戦略的SWOT分析
    BioGaia AB (BIOG B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Medical Developments International Ltd (MVP):企業の財務・戦略的SWOT分析
    Summary Medical Developments International Ltd (MDI) is a healthcare company that develops, manufactures and markets pain relief and respiratory medicine. The company provides products such as penthrox, asthma and COPD, medical devices and veterinary products. It offers asthma and COPD products whic …
  • Kyivstar JSC:企業の戦略的SWOT分析
    Kyivstar JSC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Tonix Pharmaceuticals Holding Corp (TNXP):製薬・医療:M&Aディール及び事業提携情報
    Summary Tonix Pharmaceuticals Holding Corp (Tonix) is a developer of pharmaceutical products to address public health challenges. The company offers pharmaceutical products and treatments for disorders of the central nervous system including fibromyalgia, post traumatic stress disorder and episodic …
  • Applied Industrial Technologies, Inc.:戦略・SWOT・企業財務分析
    Applied Industrial Technologies, Inc. - Strategy, SWOT and Corporate Finance Report Summary Applied Industrial Technologies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Leica Microsystems GmbH:医療機器:M&Aディール及び事業提携情報
    Summary Leica Microsystems GmbH (Leica), a subsidiary of Danaher Corp is a medical device company that manufactures microstructures. The company manufactures, and markets microscopes and scientific instruments. Its products include light microscopes, confocal microscopes, stereo microscopes and macr …
  • Coca-Cola Icecek A.S.:戦略・SWOT・企業財務分析
    Coca-Cola Icecek A.S. - Strategy, SWOT and Corporate Finance Report Summary Coca-Cola Icecek A.S. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Svevind AB-エネルギー分野:企業M&A・提携分析
    Summary Svevind AB (Svevind) is a renewable energy company that plans, develops and operates land-based wind power projects of different sizes. The company’s services portfolio includes wind project planning, design, sale and electricity generation. Its projects include Gabrielsberget, Hornefors, Gr …
  • SNC-Lavalin Group Inc.:企業の戦略・SWOT・財務分析
    SNC-Lavalin Group Inc. - Strategy, SWOT and Corporate Finance Report Summary SNC-Lavalin Group Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Original BioMedicals Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Original BioMedicals Co Ltd (OBM) is a biotechnology company that develops new drug delivering systems to deal with unmet clinical needs in the therapeutic areas of oncology, hematology and immunology. The company’s pipeline products include A01, A02 and P01. Its pipeline product OBM-A01 is …
  • Taisho Pharmaceutical Holdings Co Ltd:企業のM&A・事業提携・投資動向
    Taisho Pharmaceutical Holdings Co Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Taisho Pharmaceutical Holdings Co Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed report …
  • Antabio SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary Antabio SAS (Antabio) is a biopharmaceutical company that develops novel antibacterials targeting drug-resistant pathogens. The company’s pipeline products comprise Metallo Beta-Lactamases inhibitors, Pseudomonas Biofilms inhibitors and others. It uses in vitro technologies and bacterial dis …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆